Status:
TERMINATED
Immunoadsorption in Patients With Severe Systemic Sclerosis
Lead Sponsor:
GWT-TUD GmbH
Collaborating Sponsors:
Miltenyi Biomedicine GmbH
Conditions:
Systemic Scleroderma
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.
Eligibility Criteria
Inclusion
- systemic sclerosis according to the ACE-criteria
- severe pulmonary manifestation with reduced DLCO
- signed informed consent
Exclusion
- inadequate peripheral venous access
- participation in another clinical trial
- heart failure
- pronounced allergic diathesis, particularly in case of known hypersensitivity to drugs and/or materials used in the extracorporeal circuit
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01410903
Start Date
April 1 2011
End Date
August 1 2012
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Dresden
Dresden, Germany, 01307